Inhibrx's market cap is currently ―. The company's EPS TTM is $-5.031; its P/E ratio is -6.90; Inhibrx is scheduled to report earnings on May 6, 2024, and the estimated EPS forecast is $-1.01. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 1.63M	$ 119.00K	$ 30.00K	$ 17.00K	$ 274.00K
Gross Profit	$ 1.63M	$ 119.00K	$ 30.00K	$ 17.00K	$ 274.00K
EBIT	-	$ -51.79M	$ -47.05M	$ -43.84M	$ -35.57M
EBITDA	-	-	$ -45.54M	$ -42.34M	$ -34.01M
Net Income Common Stockholders	$ -93.60M	$ -51.79M	$ -47.05M	$ -48.92M	$ -40.91M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 277.92M	$ 337.33M	$ 192.49M	$ 234.30M	$ 273.90M
Total Assets	$ 307.89M	$ 372.73M	$ 212.84M	$ 251.28M	$ 290.88M
Total Debt	$ 210.14M	$ 209.38M	$ 208.61M	$ 207.85M	$ 207.10M
Net Debt	$ -67.78M	$ -127.95M	$ 16.12M	$ -26.45M	$ -66.80M
Total Liabilities	$ 264.39M	$ 243.14M	$ 237.98M	$ 238.58M	$ 232.82M
Stockholders Equity	$ 43.50M	$ 129.59M	$ -24.81M	$ 15.12M	$ 58.06M
Cash Flow	-
Free Cash Flow	-	-	$ -42.62M	$ -39.97M	$ -30.87M
Operating Cash Flow	$ -56.82M	$ -54.24M	$ -42.30M	$ -39.94M	$ -30.60M
Investing Cash Flow	$ -3.44M	$ -811.00K	$ -317.00K	$ -23.00K	$ -267.00K
Financing Cash Flow	$ 860.00K	$ 199.89M	$ 854.00K	$ 356.00K	$ 158.66M

Currency in USD

Inhibrx Earnings and Revenue History

Income Statement >

Inhibrx Debt to Assets

Balance Sheet >

Inhibrx Cash Flow

Cash Flow >

Inhibrx Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing